Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project
| Status: | Recruiting |
|---|---|
| Conditions: | Breast Cancer, Ovarian Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 11/2/2017 |
| Start Date: | October 1, 2016 |
| End Date: | September 1, 2021 |
| Contact: | Mark L Andrews, MA |
| Email: | MAndrews@salud.unm.edu |
| Phone: | 505-272-4359 |
Comparative Effectiveness of Interventions to Increase Guideline-based Genetic Counseling in Ethnically and Geographically Diverse Cancer Survivors
GRACE is a randomized 3-arm trial to determine the comparative effectiveness of two remote
cancer communication interventions: 1) a targeted generic print (TP), or 2) a tailored
telephone-based counseling and navigation intervention (TCN).
cancer communication interventions: 1) a targeted generic print (TP), or 2) a tailored
telephone-based counseling and navigation intervention (TCN).
There is increasing evidence that activated and engaged patients who are equipped with
necessary skills and information are more likely to follow through with recommended care and
have better health outcomes at reduced costs. Identification of individuals at increased risk
of hereditary breast and ovarian cancer (HBOC) is crucial for cancer survivors and their
families to benefit from biomedical advances in cancer prevention, early detection, treatment
and survivorship. The primary purpose of this study is to assess the feasibility and
acceptability of two remote interventions aimed at promoting cancer genetic risk assessment
(CGRA) for HBOC. The randomized controlled trial will have 3 arms: usual care (UC) vs.
targeted generic print (TP) vs. tailored telephone counseling and navigation intervention
(TCN).
necessary skills and information are more likely to follow through with recommended care and
have better health outcomes at reduced costs. Identification of individuals at increased risk
of hereditary breast and ovarian cancer (HBOC) is crucial for cancer survivors and their
families to benefit from biomedical advances in cancer prevention, early detection, treatment
and survivorship. The primary purpose of this study is to assess the feasibility and
acceptability of two remote interventions aimed at promoting cancer genetic risk assessment
(CGRA) for HBOC. The randomized controlled trial will have 3 arms: usual care (UC) vs.
targeted generic print (TP) vs. tailored telephone counseling and navigation intervention
(TCN).
Inclusion
Breast cancer survivor eligibility:
- Inclusion
- Hispanic or non-Hispanic
- Female
- 21 years of age or older
- English-speaking
- Breast cancer history
- breast cancer at the age of 50 or younger OR
- triple negative breast cancer OR
- two or more primary breast cancers
Exclusion
• Have had prior genetic counseling or testing for hereditary breast and/or
Ovarian cancer survivor eligibility:
- Inclusion
- Hispanic or non-Hispanic
- Female
- 21 years of age or older
- English-speaking
- History of ovarian, fallopian, or peritoneal cancer diagnosed at any age
Exclusion
• Have had prior genetic counseling or testing for hereditary breast and/or ovarian cancer
We found this trial at
1
site
University of New Mexico Founded in 1889 as New Mexico’s flagship institution, the University of...
Click here to add this to my saved trials
